Differentially expressed genes in sputum after azithromycin treatment involved in immune system processes
| Gene symbol | Gene name | p-value | Fold change | Regulation | Probe ID | Accession |
| HLA-H | Major histocompatibility complex, class I, H (pseudogene), non-coding RNA | 0.038 | 2.3 | down | 1980592 | NR_001434.1 |
| HLA-DRB4 | Major histocompatibility complex, class II, DR beta 4 | 0.045 | 2.0 | down | 510079 | NM_021983.4 |
| CD83 | CD83 molecule, transcript variant 1 | 0.047 | 2.0 | down | 6620026 | NM_004233.3 |
| HLA-A | Major histocompatibility complex, class I, A | 0.038 | 1.9 | down | 3400438 | NM_002116.5 |
| HLA-DPA1 | Major histocompatibility complex, class II, DP alpha 1 | 0.049 | 1.9 | down | 1190039 | NM_033554.2 |
| GBP1 | Guanylate binding protein 1, interferon-inducible, 67 kDa | 0.039 | 1.9 | down | 2190148 | NM_002053.1 |
| CFD | Complement factor D (adipsin) | 0.043 | 1.9 | down | 1240152 | NM_001928.2 |
| CTSC | Cathepsin C, transcript variant 1 | 0.039 | 1.8 | down | 5270367 | NM_001814.2 |
| HLA-E | Major histocompatibility complex, class I, E | 0.041 | 1.8 | down | 1030747 | NM_005516.4 |
| HLA-B | Major histocompatibility complex, class I, B | 0.038 | 1.8 | down | 5310168 | NM_005514.5 |
| ARHGDIB | Rho GDP dissociation inhibitor beta | 0.045 | 1.7 | down | 1570193 | NM_001175.4 |
| HLA-DRA | Major histocompatibility complex, class II, DR alpha | 0.040 | 1.7 | down | 2570564 | NM_019111.3 |
| CYBB | Cytochrome b-245, beta polypeptide | 0.038 | 1.7 | down | 840168 | NM_000397.2 |
| MSN | Moesin | 0.042 | 1.7 | down | 730332 | NM_002444.2 |
| CCL23 | Chemokine (C-C motif) ligand 23, transcript variant CKbeta8 | 0.038 | 1.6 | down | 6110343 | NM_145898.1 |
| IFI30 | Interferon, gamma-inducible protein 30 | 0.045 | 1.6 | down | 2000300 | NM_006332.3 |
| CD14 | CD14 molecule, transcript variant 1 | 0.047 | 1.6 | down | 7000369 | NM_000591.2 |
| CKLF | Chemokine-like factor, transcript variant 6 | 0.043 | 1.6 | down | 2760519 | NM_001040139.1 |
| GBP2 | Guanylate binding protein 2, interferon-inducible | 0.041 | 1.6 | down | 1940162 | NM_004120.3 |
| IFITM3 | Interferon induced transmembrane protein 3 (1-8U) | 0.044 | 1.6 | down | 6650242 | NM_021034.2 |
| ITGB2 | Integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) | 0.045 | 1.5 | down | 7200156 | NM_000211.1 |
| CD86 | CD86 antigen (CD28 antigen ligand 2, B7-2 antigen), transcript variant 1 | 0.038 | 1.5 | down | 4040022 | NM_175862.2 |
| BCAP31 | B-cell receptor-associated protein 31 | 0.038 | 1.5 | down | 6450138 | NM_005745.6 |
| CCL5 | Chemokine (C-C motif) ligand 5 | 0.038 | 1.5 | down | 620717 | NM_002985.2 |
| DBNL | Drebrin-like, transcript variant 2 | 0.049 | 1.5 | down | 2140671 | NM_001014436.1 |
| DCLRE1C | DNA cross-link repair 1C (PSO2 homolog, Saccharomyces cerevisiae), transcript variant b | 0.038 | 2.0 | up | 6860647 | NM_022487.2 |
| FCAR | Fc fragment of IgA, receptor for, transcript variant 9 | 0.049 | 2.0 | up | 4250193 | NM_133279.1 |
| TNFSF15 | Tumor necrosis factor (ligand) superfamily, member 15 | 0.043 | 2.0 | up | 3370128 | NM_005118.2 |
| ZNF160 | Zinc finger protein 160, transcript variant 2 | 0.0378 | 1.9 | up | 6980474 | NM_198893.1 |
| SPN | Sialophorin, transcript variant 1 | 0.0378 | 1.8 | up | 10358 | NM_001030288.1 |
| TNFSF14 | Tumor necrosis factor (ligand) superfamily, member 14, transcript variant 2 | 0.048 | 1.7 | up | 1170673 | NM_172014.1 |
| DCLRE1C | DNA cross-link repair 1C (PSO2 homolog, S. cerevisiae), transcript variant c | 0.0388 | 1.7 | up | 430044 | NM_001033858.1 |
| FCGR3A | Fc fragment of IgG, low affinity IIIa, receptor (CD16a), transcript variant 1 | 0.0378 | 1.6 | up | 4050039 | NM_000569.6 |
| LAX1 | Lymphocyte transmembrane adaptor 1 | 0.0378 | 1.6 | up | 580411 | NM_017773.2 |
| KIR2DS5 | Killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 5 | 0.0379 | 1.5 | up | 2070561 | NM_014513.1 |